Related references
Note: Only part of the references are listed.Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients
Heather Hampel et al.
GYNECOLOGIC ONCOLOGY (2021)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Mev Dominguez-Valentin et al.
GENETICS IN MEDICINE (2020)
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2020)
The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded material
Anne M. L. Jansen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas
Alicia Leon-Castillo et al.
JOURNAL OF PATHOLOGY (2020)
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing
Danielle Cohen et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
Neal C. Fiamchander et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer
Tristan M. Snowsill et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
John Burn et al.
LANCET (2020)
The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study
Neil A. J. Ryan et al.
PLOS MEDICINE (2020)
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
Nanda Horeweg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
N. A. J. Ryan et al.
GENETICS IN MEDICINE (2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2019)
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Characteristics of Lynch syndrome associated ovarian cancer
J. M. Woolderink et al.
GYNECOLOGIC ONCOLOGY (2018)
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers
Guo-Chen Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers
Guo-Chen Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer Risks for PMS2-Associated Lynch Syndrome
Sanne W. ten Broeke et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
B. G. Wortman et al.
BRITISH JOURNAL OF CANCER (2018)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
E. Stelloo et al.
ANNALS OF ONCOLOGY (2017)
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome Implications for Stratified Surveillance Strategies
Neil A. J. Ryan et al.
JAMA ONCOLOGY (2017)
Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters
Janelle B. Pakish et al.
CLINICAL CANCER RESEARCH (2017)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
Sigurdis Haraldsdottir et al.
GENETICS IN MEDICINE (2016)
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J. Goodfellow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Colon and Endometrial Cancers With Mismatch Repair Deficiency Can Arise From Somatic, Rather Than Germline, Mutations
Sigurdis Haraldsdottir et al.
GASTROENTEROLOGY (2014)
Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors
Arjen R. Mensenkamp et al.
GASTROENTEROLOGY (2014)
Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers
Willemina R. R. Geurts-Giele et al.
JOURNAL OF PATHOLOGY (2014)
Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
Aung Ko Win et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
Wenche Sjursen et al.
JOURNAL OF MEDICAL GENETICS (2010)
Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
H Hampel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome
KH Lu et al.
OBSTETRICS AND GYNECOLOGY (2005)
Share Paper
